Means Investment CO. Inc. Reduces Holdings in UnitedHealth Group Incorporated $UNH

Means Investment CO. Inc. cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 57.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,833 shares of the healthcare conglomerate’s stock after selling 2,488 shares during the period. Means Investment CO. Inc.’s holdings in UnitedHealth Group were worth $633,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in UNH. Centerpoint Advisors LLC grew its holdings in UnitedHealth Group by 5.8% in the third quarter. Centerpoint Advisors LLC now owns 1,261 shares of the healthcare conglomerate’s stock worth $436,000 after purchasing an additional 69 shares during the period. AlTi Global Inc. increased its position in UnitedHealth Group by 85.1% during the 3rd quarter. AlTi Global Inc. now owns 19,759 shares of the healthcare conglomerate’s stock valued at $6,823,000 after buying an additional 9,082 shares in the last quarter. Profund Advisors LLC boosted its holdings in UnitedHealth Group by 0.7% in the third quarter. Profund Advisors LLC now owns 15,748 shares of the healthcare conglomerate’s stock worth $5,438,000 after acquiring an additional 107 shares in the last quarter. Linden Thomas Advisory Services LLC increased its holdings in shares of UnitedHealth Group by 2.8% during the third quarter. Linden Thomas Advisory Services LLC now owns 4,836 shares of the healthcare conglomerate’s stock valued at $1,670,000 after acquiring an additional 134 shares in the last quarter. Finally, D.B. Root & Company LLC boosted its stake in UnitedHealth Group by 21.0% in the 3rd quarter. D.B. Root & Company LLC now owns 2,050 shares of the healthcare conglomerate’s stock worth $708,000 after purchasing an additional 356 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Down 0.5%

UNH stock opened at $275.17 on Tuesday. The business’s 50-day moving average price is $324.91 and its 200-day moving average price is $323.43. The stock has a market cap of $249.26 billion, a P/E ratio of 20.86, a PEG ratio of 1.27 and a beta of 0.41. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $606.36. The company has a quick ratio of 0.82, a current ratio of 0.79 and a debt-to-equity ratio of 0.72.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, beating the consensus estimate of $2.09 by $0.02. The business had revenue of $113.22 billion for the quarter, compared to the consensus estimate of $113.38 billion. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The company’s revenue for the quarter was up 12.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $6.81 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of recent analyst reports. Jefferies Financial Group cut their price target on shares of UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating on the stock in a report on Wednesday, January 28th. UBS Group reduced their target price on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating for the company in a report on Wednesday, January 28th. Wells Fargo & Company dropped their price objective on UnitedHealth Group from $400.00 to $370.00 and set an “overweight” rating on the stock in a research report on Friday, January 30th. Royal Bank Of Canada lowered their target price on shares of UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating on the stock in a research note on Wednesday, January 28th. Finally, Truist Financial decreased their price objective on shares of UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating for the company in a report on Monday, February 2nd. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus target price of $372.13.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.